Abstract
Mutational landscape of CLL is now known to include recurrent non-synonymous mutations in SF3B1, a core splicing factor. About 5–10% of newly diagnosed CLL harbor these mutations which are typically limited to HEAT domains in the carboxyl-terminus of the protein. Importantly, the mutations are not specific to CLL but also present in several unrelated clonal disorders. Analysis of patient samples and cell lines has shown the primary splicing aberration in SF3B1-mutant cells to the use of novel or “cryptic” 3′ splice sites (3SS). Advances in genome-editing and next-generation sequencing (NGS) have allowed development of isogenic models and detailed analysis of changes to the transcriptome with relative ease. In this manuscript, we focus on two relevant methods to study splicing factor mutations in CLL: development of isogenic scalable cell lines and informatics analysis of RNA-Seq datasets.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Amin NA, Malek SN (2016) Gene mutations in chronic lymphocytic leukemia. Semin Oncol 43:215–221. https://doi.org/10.1053/j.seminoncol.2016.02.002
Quesada V, Conde L, Villamor N et al (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44:47–52. https://doi.org/10.1038/ng.1032
Wang L, Lawrence MS, Wan Y et al (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365:2497–2506. https://doi.org/10.1056/NEJMoa1109016
Biankin AV, Waddell N, Kassahn KS et al (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491:399–405. https://doi.org/10.1038/nature11547
Ellis MJ, Ding L, Shen D et al (2012) Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486:353–360. https://doi.org/10.1038/nature11143
Harbour JW, Roberson EDO, Anbunathan H et al (2013) Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 45:133–135. https://doi.org/10.1038/ng.2523
Papaemmanuil E, Cazzola M, Boultwood J et al (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365:1384–1395. https://doi.org/10.1056/NEJMoa1103283
Yoshida K, Sanada M, Shiraishi Y et al (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64–69. https://doi.org/10.1038/nature10496
Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, Cancer Genome Atlas Research Network (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169:1327–1341.e23. https://doi.org/10.1016/j.cell.2017.05.046
Hahn CN, Scott HS (2011) Spliceosome mutations in hematopoietic malignancies. Nat Genet 44:9–10. https://doi.org/10.1038/ng.1045
Strefford JC, Sutton L-A, Baliakas P et al (2013) Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 27:2196–2199. https://doi.org/10.1038/leu.2013.98
Nadeu F, Delgado J, Royo C et al (2016) Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. Blood 127:2122–2130. https://doi.org/10.1182/blood-2015-07-659144
Te Raa GD, Derks IAM, Navrkalova V et al (2015) The impact of SF3B1 mutations in CLL on the DNA-damage response. Leukemia 29:1133–1142. https://doi.org/10.1038/leu.2014.318
DeBoever C, Ghia EM, Shepard PJ et al (2015) Transcriptome sequencing reveals potential mechanism of cryptic 3′ splice site selection in SF3B1-mutated cancers. PLoS Comput Biol 11:e1004105. https://doi.org/10.1371/journal.pcbi.1004105
Wang L, Brooks AN, Fan J et al (2016) Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia. Cancer Cell 30:750–763. https://doi.org/10.1016/j.ccell.2016.10.005
Alsafadi S, Houy A, Battistella A et al (2016) Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat Commun 7:10615. https://doi.org/10.1038/ncomms10615
Darman RB, Seiler M, Agrawal AA et al (2015) Cancer-associated SF3B1 hotspot mutations induce cryptic 3? Splice site selection through use of a different branch point. Cell Rep 13:1033–1045. https://doi.org/10.1016/j.celrep.2015.09.053
Kesarwani AK, Ramirez O, Gupta AK et al (2016) Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3′ splice sites within RNA secondary structures. Oncogene. https://doi.org/10.1038/onc.2016.279
Mupo A, Seiler M, Sathiaseelan V et al (2016) Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts. Leukemia. https://doi.org/10.1038/leu.2016.251
Obeng EA, Chappell RJ, Seiler M et al (2016) Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell 30:404–417. https://doi.org/10.1016/j.ccell.2016.08.006
Wang C, Chua K, Seghezzi W et al (1998) Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev 12:1409–1414
Effenberger KA, Urabe VK, Jurica MS (2017) Modulating splicing with small molecular inhibitors of the spliceosome. Wiley Interdiscip Rev RNA 8:n/a–n/a. https://doi.org/10.1002/wrna.1381
Cretu C, Schmitzová J, Ponce-Salvatierra A et al (2016) Molecular architecture of SF3b and structural consequences of its cancer-related mutations. Mol Cell 64:307–319. https://doi.org/10.1016/j.molcel.2016.08.036
Fica SM, Nagai K (2017) Cryo-electron microscopy snapshots of the spliceosome: structural insights into a dynamic ribonucleoprotein machine. Nat Struct Mol Biol 24:791–799. https://doi.org/10.1038/nsmb.3463
Shi Y (2017) Mechanistic insights into precursor messenger RNA splicing by the spliceosome. Nat Rev Mol Cell Biol 18:655–670. https://doi.org/10.1038/nrm.2017.86
Will CL, Lührmann R (2011) Spliceosome structure and function. Cold Spring Harb Perspect Biol 3. https://doi.org/10.1101/cshperspect.a003707
Cavellán E, Asp P, Percipalle P, Farrants A-KO (2006) The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription. J Biol Chem 281:16264–16271. https://doi.org/10.1074/jbc.M600233200
de Almeida SF, Grosso AR, Koch F et al (2011) Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat Struct Mol Biol 18:977–983. https://doi.org/10.1038/nsmb.2123
Isono K, Mizutani-Koseki Y, Komori T et al (2005) Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes Dev 19:536–541. https://doi.org/10.1101/gad.1284605
Listerman I, Sapra AK, Neugebauer KM (2006) Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat Struct Mol Biol 13:815–822. https://doi.org/10.1038/nsmb1135
Kfir N, Lev-Maor G, Glaich O et al (2015) SF3B1 association with chromatin determines splicing outcomes. Cell Rep. https://doi.org/10.1016/j.celrep.2015.03.048
Sánchez-Rivera FJ, Jacks T (2015) Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer 15:387–395. https://doi.org/10.1038/nrc3950
Zhao W, He X, Hoadley KA et al (2014) Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics 15:419. https://doi.org/10.1186/1471-2164-15-419
Conesa A, Madrigal P, Tarazona S et al (2016) A survey of best practices for RNA-seq data analysis. Genome Biol 17:13. https://doi.org/10.1186/s13059-016-0881-8
Alamancos GP, Agirre E, Eyras E (2014) Methods to study splicing from high-throughput RNA sequencing data. Methods Mol Biol 1126:357–397. https://doi.org/10.1007/978-1-62703-980-2_26
Shen S, Park JW, Lu Z et al (2014) rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A 111:E5593–E5601. https://doi.org/10.1073/pnas.1419161111
Ran FA, Hsu PD, Wright J et al (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8:2281–2308. https://doi.org/10.1038/nprot.2013.143
Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. https://doi.org/10.1093/bioinformatics/btu170
Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Murthy, T., Paul, K.V., Minella, A.C., Pillai, M.M. (2019). The Development and Use of Scalable Systems for Studying Aberrant Splicing in SF3B1-Mutant CLL. In: Malek, S. (eds) Chronic Lymphocytic Leukemia. Methods in Molecular Biology, vol 1881. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8876-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8876-1_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8875-4
Online ISBN: 978-1-4939-8876-1
eBook Packages: Springer Protocols